89 related articles for article (PubMed ID: 1123659)
1. Experimental cerebral vasospasm. Part 2: effects of vasoactive drugs and sympathectomy on early and late spasm.
Nagai H; Noda S; Mabe H
J Neurosurg; 1975 Apr; 42(4):420-8. PubMed ID: 1123659
[TBL] [Abstract][Full Text] [Related]
2. [Experimental Subarachnoid hemmorrhage in dogs--effect of various drugs and sympathectomy on cerebral arterial spasm (author's transl)].
Noda S
No Shinkei Geka; 1975 Sep; 3(9):747-55. PubMed ID: 1239688
[TBL] [Abstract][Full Text] [Related]
3. [The role of sympathetic nerve and vasoactive amines in experimental cerebral vasospasm in dogs (author's transl)].
Mabe H
No Shinkei Geka; 1978 Jun; 6(6):555-61. PubMed ID: 673135
[TBL] [Abstract][Full Text] [Related]
4. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
[TBL] [Abstract][Full Text] [Related]
5. Observations on the effects of intrathecal papaverine in experimental vasospasm.
Ogata M; Marshall BM; Lougheed WM
J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882
[No Abstract] [Full Text] [Related]
6. Current concepts in the etiology and treatment of vasospasm.
Echlin FA
Clin Neurosurg; 1968; 15():133-60. PubMed ID: 5001545
[No Abstract] [Full Text] [Related]
7. Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm.
Kuwayama A; Zervas NT; Shintani A; Pickren KS
Stroke; 1972; 3(1):27-33. PubMed ID: 5008302
[No Abstract] [Full Text] [Related]
8. Alteration of experimental cerebral vasospasm by adrenergic blockade.
Flamm ES; Yasargil MG; Ransohoff J
J Neurosurg; 1972 Sep; 37(3):294-301. PubMed ID: 4403561
[No Abstract] [Full Text] [Related]
9. Comparative effectiveness of alpha-blockade and beta-stimulation in modifying experimental basilar arterial spasm.
Smigiel MR; Sundt TM
J Neurosurg; 1974 Sep; 41(3):300-5. PubMed ID: 4412524
[No Abstract] [Full Text] [Related]
10. Reserpine and cerebral vasospasm.
Watts C
Stroke; 1977; 8(1):112-4. PubMed ID: 835151
[TBL] [Abstract][Full Text] [Related]
11. [The experimental study of the cerebral vasospasm--the micro-circulation on the hypothalamus and the brain stem (author's transl)].
Katsumata T
No Shinkei Geka; 1975 Nov; 3(11):939-46. PubMed ID: 1240614
[TBL] [Abstract][Full Text] [Related]
12. Arterial spasm in subarachnoid haemorrhage. A clinical and experimental study.
Allcock JM
Acta Radiol Diagn (Stockh); 1966; 5():73-82. PubMed ID: 5957866
[No Abstract] [Full Text] [Related]
13. Sustained release of papaverine for the treatment of cerebral vasospasm: in vitro evaluation of release kinetics and biological activity.
Heffez DS; Leong KW
J Neurosurg; 1992 Nov; 77(5):783-7. PubMed ID: 1403123
[TBL] [Abstract][Full Text] [Related]
14. Modification of the antinociceptive action of aminopyrine by an -adrenergic blocking agent (phentolamine) and 2 -adrenergic blocking drugs (propranolol, oxoprenolol).
Jaques R; Helfer H
Pharmacology; 1971; 5(2):89-96. PubMed ID: 4398326
[No Abstract] [Full Text] [Related]
15. Subarachnoid administration of phentolamine for experimental cerebral vasospasm.
Flamm ES; Ransohoff J
Surg Forum; 1972; 23(0):450-2. PubMed ID: 4671154
[No Abstract] [Full Text] [Related]
16. [Effect of experimental subarachnoid hemorrhage on calcium incorporation and adrenergic innervation of the cerebral arteries of the cat].
Marín J; Rivilla F; Salaices M; Lobato RD; Burgos J; Sánchez-Ferrer CF; Fernández A
Rev Esp Fisiol; 1985 Dec; 41(4):381-6. PubMed ID: 3938040
[TBL] [Abstract][Full Text] [Related]
17. [A model for intracranial vasospasm in subarachnoid hemorrhage].
Jin Y; Proust F; Rabehenoina A; Seigneur N; Creissard P; Tadie M
Neurochirurgie; 1991; 37(1):44-9. PubMed ID: 2017293
[TBL] [Abstract][Full Text] [Related]
18. Cerebral arteriolar spasm inhibited by beta-adrenergic blocking agents.
Rosenblum WI
Arch Neurol; 1969 Sep; 21(3):296-302. PubMed ID: 4389850
[No Abstract] [Full Text] [Related]
19. Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition.
Andrews P; Papadakis N; Gavras H
Stroke; 1982; 13(4):480-3. PubMed ID: 6179264
[TBL] [Abstract][Full Text] [Related]
20. Cerebral vasospasm. Part I. In cerebral vascular malformations.
Mohr JP; Kase CS
Rev Neurol (Paris); 1983; 139(2):99-113. PubMed ID: 6410488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
